Riskpilot← Back to searchSign inGet full accessKLINIKK S AS
ASActiveOrg 997960319Sjøgata 8, 4. Etasje, 8006 BodøOther human health activities n.e.c. · NACE 8699Est. 20125 employeeswww.klinikks.no
Revenue 2024
NOK 10,5M
+2% vs 2023
EBITDA margin
11.5%
-51% vs 2023
Equity ratio
70.1%
Financial strength
Net profit 2024
NOK 2,2M
+20% vs 2023
| Revenue | NOK 10,5M | +2% |
| EBITDA | NOK 1,2M | -51% |
| Net profit | NOK 2,2M | +20% |
| Total assets | NOK 3,4M | -44% |
| Equity | NOK 2,4M | -43% |
| Employees | 5 | — |
Legal name
KLINIKK S AS
Org number
997960319
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
14. februar 2012
Share capital
NOK 30 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Helsetjenester, etter- og videreutdanning, informasjon, utleie, investering i fast eiendom og verdipapirer, og det som naturlig hører hertil, herunder å delta i selskaper med lignende virksomheter.
Address
Sjøgata 8, 4. Etasje, 8006 Bodø
Phone
+4775524650
Email
post@klinikks.no
Website
www.klinikks.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 9 210 | 9 388 | 9 618 | 10 322 | 10 478 |
| Staff expenses | −4 594 | −5 485 | −4 993 | −5 428 | −4 312 |
| EBITDA | 1 016 | 262 | 747 | 2 472 | 1 206 |
| Depreciation & amort. | −462 | −228 | −131 | −138 | −123 |
| EBIT | 554 | 34 | 615 | 2 334 | 1 083 |
| Net financials | −13 | −7 | −0 | −3 | 1 325 |
| Profit before tax | 541 | 27 | 615 | 2 331 | 2 409 |
| Tax | 163 | 9 | 106 | 497 | 203 |
| Net profit | 378 | 18 | 509 | 1 834 | 2 205 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 606 | 3 470 | 3 952 | 6 116 | 3 422 |
| Equity | 1 955 | 1 972 | 2 482 | 4 194 | 2 400 |
| Long-term debt | 400 | 320 | 240 | 160 | 80 |
| Short-term debt | 1 252 | 1 178 | 1 231 | 1 761 | 942 |
| Total debt | 1 652 | 1 498 | 1 471 | 1 921 | 1 022 |
EBITDA margin
11.5%
This company
15.8%
Market median
-27% vs market
20202024
Equity ratio
70.1%
This company
38.2%
Market median
+84% vs market
20202024
Return on equity
91.9%
This company
18.4%
Market median
+399% vs market
20202024
Net profit margin
21.0%
This company
8.1%
Market median
+159% vs market
20202024
Asset turnover
3.06×
This company
1.12×
Market median
+173% vs market
20202024
Debt / equity
0.43×
This company
0.62×
Market median
+31% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KT Chief Executive Officer | Chief Executive Officer | 2016 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2015 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
KLINIKK S AS 
SJØGATA EIENDOMSINVEST ASBoard members of KLINIKK S AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Katrin Tjærandsen | Chief Executive Officer | 0 companies |
| Alexander Skau | Chairman | 0 companies |